Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Goodwill: 2015-2022

Historic Goodwill for Aytu Biopharma (AYTU) over the last 5 years, with Mar 2022 value amounting to $8.6 million.

  • Aytu Biopharma's Goodwill fell 86.87% to $8.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $8.6 million, marking a year-over-year decrease of 86.87%. This contributed to the annual value of $65.8 million for FY2021, which is 134.25% up from last year.
  • As of Q1 2022, Aytu Biopharma's Goodwill stood at $8.6 million, which was down 81.37% from $46.3 million recorded in Q4 2021.
  • Over the past 5 years, Aytu Biopharma's Goodwill peaked at $65.8 million during Q1 2021, and registered a low of $8.6 million during Q1 2022.
  • Its 3-year average for Goodwill is $39.7 million, with a median of $37.2 million in 2020.
  • As far as peak fluctuations go, Aytu Biopharma's Goodwill spiked by 134.25% in 2021, and later slumped by 86.87% in 2022.
  • Over the past 4 years, Aytu Biopharma's Goodwill (Quarterly) stood at $15.4 million in 2019, then spiked by 82.56% to $28.1 million in 2020, then skyrocketed by 65.00% to $46.3 million in 2021, then slumped by 86.87% to $8.6 million in 2022.
  • Its last three reported values are $8.6 million in Q1 2022, $46.3 million for Q4 2021, and $46.3 million during Q3 2021.